MEG3 and colorectal cancer: Additionally, miR-708 enhances STAT3 activation by targeting the 3’UTR of SOCS3, and the decreased expression of MEG3 in colorectal cancer (CRC) tissues and cells leads to a reduction in SOCS3 levels, promoting the malignant proliferation of colon stem cells and CRC cell lines.